insights_auto
EVGN 주가가 하락한 이유: 8.59%?
자세히 알아보기chevron_right
EVGN:NASDAQ
Evogene Ltd
US$0.38
arrow_downward
-8.59%(-0.036) 1D
US$0.39
arrow_upward
+2.82% (+0.011)bedtime시간 외 거래
휴장: 9월 28일, 오후 4시 0분 0초 GMT-4 · USD
search
모든 종목 코드
1D
5D
1M
6M
YTD
1Y
5Y
최대
| 종목 코드 | 가격 | 변동 | 변동률(%) |
|---|
insights_autoEVGN의 주요 통계 생성 중...
시가
US$0.41
고가
US$0.45
저가
US$0.35
시가총액
594.31만
평균 거래량
22.60만
거래량
0.00
52주 최고가
US$1.50
52주 최저가
US$0.35
EPS
-US$0.91
베타
1.40
유통 주식수
1580.10만
직원 수
38
시가
US$0.41
고가
US$0.45
저가
US$0.35
시가총액
594.31만
평균 거래량
22.60만
거래량
0.00
52주 최고가
US$1.50
52주 최저가
US$0.35
EPS
-US$0.91
베타
1.40
유통 주식수
1580.10만
직원 수
38
뉴스 기사
웹 소스 및 뉴스 파트너 제공
프로필
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Evogene Ltd에 관한 정보